Brief: Zelira Therapeutics Secures Us$8.6 Million Cornerstone Funding

Zelira Therapeutics

15/02/2023 01:12

Feb 15 (Reuters) - Zelira Therapeutics Ltd  ZLD.AX :
    * SECURES US$8.6 MILLION CORNERSTONE FUNDING FOR HOPE 1 US
FDA
CLINICAL TRIALS
    * TO RAISE UP TO ADDITIONAL CIRCA US$26 MILLION IN SPV TO
FUND
HOPE 1 US FDA TRIALS

Source text for Eikon:  ID:nASX5gnJgW 
Further company coverage:  ZLD.AX